Your browser doesn't support javascript.
loading
secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics.
Kumar, Harish; Mazumder, Suman; Chakravarti, Sayak; Sharma, Neeraj; Mukherjee, Ujjal Kumar; Kumar, Shaji; Baughn, Linda B; Van Ness, Brian G; Mitra, Amit Kumar.
Afiliación
  • Kumar H; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.
  • Mazumder S; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.
  • Chakravarti S; Center for Pharmacogenomics and Single-Cell Omics initiative (AUPharmGx), Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.
  • Sharma N; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.
  • Mukherjee UK; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Kumar S; Department of Business Administration, University of Illinois at Urbana-Champaign, Champaign, IL, USA.
  • Baughn LB; Carle Illinois College of Medicine, University of Illinois at Urbana-Champaign, Champaign, IL, USA.
  • Van Ness BG; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Mitra AK; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Blood Cancer J ; 12(3): 39, 2022 03 09.
Article en En | MEDLINE | ID: mdl-35264575
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos